ASCO 2013 Video: Can we target KRAS effectively in advanced NSCLC?

Portal Forums Lung/Thoracic Cancer General Lung/Thoracic Cancer ASCO 2013 Video: Can we target KRAS effectively in advanced NSCLC?

This topic contains 0 replies, has 1 voice, and was last updated by JimC Forum Moderator JimC Forum Moderator 4 years, 5 months ago.

Viewing 1 post (of 1 total)
Author Posts   
Author Posts
July 3, 2013 at 9:03 am  #1257711    
JimC Forum Moderator
JimC Forum Moderator

In today’s ASCO 2013 video, Drs. Mary Pinder, Nate Pennell, and Jack West discuss developments with selumetinib and other MEK inhibitors as a potential target for the 20-25% of NSCLC patients with a KRAS mutation.

You can view the video here: http://cancergrace.org/lung/2013/07/03/mek-inhibitor-update-asco-2013/

We welcome your questions and comments here.

JimC
Forum moderator


Jul 2008 Wife Liz (51/never smoker) Dx Stage IV NSCLC EGFR exon 19
4 cycles Carbo/alimta, 65% shrinkage
Tarceva maintenance
Mar 2010 progression, added Alimta, stable
Sep 2010 multiple brain mets, WBR
Oct 2010 large pericardial effusion, tamponade
Jan 2011 progression, start abraxane
Jun 2011-New liver, brain mets, add Tarceva
Oct 2011-Dx Leptomeningeal carcinomatosis; pulsed Tarceva
At rest Nov 4 2011
Since then: http://cancergrace.org/blog/jim-and-lisa

Viewing 1 post (of 1 total)

You must be logged in to reply to this topic.